Non-anticoagulant heparins: glycan-mediated immune modulation and therapeutic applications

• by Yaner Gu, Qiong Wang, Juan Fang, Jing Chen, Kaiting Hong, Zhanwei Zhang, Syed Shams Ul Hassan, Yin Chen, Xuqian Zhang

• July 21, 2026

Preoperative 18F-FDG PET/CT as a surgical triage tool for synchronous neoplasm detection in acute left-sided obstructive colorectal cancer: a two-institution retrospective cohort study

• by Kyung Uk Jung, Sung Ryol Lee, Joosung Park, Hyung Ook Kim, Hungdai Kim, Hee-Sung Song, Ji Young Lee, Yong Bog Kim, Jaemin Jo, Ji Eun Park, Hyun Joo Song, Heung Up Kim, Weon Young Chang, Ho-kyung Chun, Donghyoun Lee

• July 20, 2026

Late-phase strategies to overcome limitations of PD-1/PD-L1 therapy: a clinical development trajectory through 2030

• by Elena A. Andresyuk, Natalya O. Porozova, Georgii D. Londaridze, Ivan S. Moiseev, Polina V. Kotselyabina, Yuri B. Porozov

• July 20, 2026

The Secrets of the Gut

Going beyond the gut: why microbiome testing is the next big thing in drug development

• by Christina Casén

• July 20, 2026

• 6 min